Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Mugo, Nelly Rwamba

Kenya Medical Research Institute (Kemri)
United States

KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH 3UG1CA285132-03S1 Maria Silvina Frech, Ph.D., M.S.
Muller, Carolyn Y

University Of New Mexico Health Scis Ctr
United States

The NCI Community Oncology Research Program: The New Mexico NCORP 3UG1CA189856-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Muller, Carolyn Y

University Of New Mexico Health Scis Ctr
United States

The NCI Community Oncology Research Program: The New Mexico NCORP 3UG1CA189856-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs 3R34CA284983-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Mungo, Chemtai

Univ Of North Carolina Chapel Hill
United States

Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa 3R37CA306827-01S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Murenzi, Gad

Research For Development
United States

Rwanda CASCADE Clinical Trials Site for cervical cancer prevention 5UG1CA284908-03 Maria Silvina Frech, Ph.D., M.S.
Mustian, Karen M.

University Of Rochester
United States

URCC NCORP Research Base 3UG1CA189961-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mustian, Karen M.

University Of Rochester
United States

URCC NCORP Research Base 3UG1CA189961-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Muzumdar, Mandar Deepak

Yale University
United States

Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics 1R01CA296916-01
Mwesigwa, Betty

Makerere University Walter Reed Project
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) 5UG1CA275412-04 Maria Silvina Frech, Ph.D., M.S.
Nabavi, Sheida

University Of Connecticut Storrs
United States

SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening 5R01CA297855-02 Claire Zhu, Ph.D.
Naicker, Nivashnee

Centre/Aids Programme/Res/South Africa
United States

CAPRISA CASCADE Clinical Trials Network Clinical Research Site 5UG1CA284671-03 Maria Silvina Frech, Ph.D., M.S.
Nappi, Lucia

Provincial Health Services Authority
United States

Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 5R37CA264798-03 Guillermo Marquez, Ph.D.
Nath, Kavindra

University Of Pennsylvania
United States

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition 5R01CA228457-05 Nicholas Hodges, Ph.D.
Nelson, Randy J.

West Virginia University
United States

Mechanism Underlying Sleep Disruption by Mammary Tumors 5R21CA276027-02 Marjorie Perloff, M.D.